Immunogen, Inc. (IMGN) Tops Q2 EPS by 22c; Updates FY14 Revs Outlook

January 31, 2014 6:33 AM

Immunogen, Inc. (NASDAQ: IMGN) reported Q2 EPS of $0.04, $0.22 better than the analyst estimate of ($0.18). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found